Medicaid
AHA Comments on Provisions of the Reauthorizing and Extending America鈥檚 Community Health (REACH) Act
AHA comments on provisions of the Reauthorizing and Extending America鈥檚
Community Health (REACH) Act.
The Centers for Medicare & Medicaid Services plans to convene workgroups and technical expert panels to develop a 鈥渟treamlined, comprehensive approach to monitoring access across Medicaid delivery systems,鈥 the agency announced yesterday.
The Centers for Medicare & Medicaid Services today proposed rescinding a 2015 rule that required states to develop and submit access monitoring review plans to CMS for some Medicaid services.
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders.
The Centers for Medicare & Medicaid Services yesterday approved Louisiana鈥檚 Medicaid plan amendment allowing supplemental rebate agreement negotiations with prescription drug makers for Hepatitis C therapies.
The Centers for Medicare & Medicaid Services last week issued guidance outlining certain assurances that state Medicaid agencies should make 鈥渢o ensure that program resources are reserved for those who meet eligibility requirements.鈥
The AHA today urged the Office of Management and Budget to continue using the Consumer Price Index for All Urban Consumers (CPI-U) in making annual adjustments to the Official Poverty Measure.
Thousands of adults in Arkansas lost insurance coverage in the first six months after Medicaid work requirements were implemented, with no change in employment.
The House Energy and Commerce Committee鈥檚 Subcommittee on Health today held a hearing on expiring supplemental Medicaid funding for American Samoa, Guam, Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.
The Centers for Medicare & Medicaid Services yesterday approved a Medicaid state plan amendment allowing Washington state to negotiate supplemental rebate agreements with drug makers based on value.